缺血性卒中或短暂性脑缺血发作后他汀减量或未治疗与死亡率升高相关
该研究纳入2011年美国134家退伍军人健康管理机构中9380例缺血性卒中或TIA患者,依据入院至出院时他汀效力变化分为6组,比较30天和1年死亡率;约三分之一患者出院时未接受他汀或减量,减量及未治疗均与1年死亡率升高独立相关。
要点
- 约三分之一卒中或TIA患者出院时未接受他汀或他汀减量。
- 他汀减量与未治疗均与1年死亡率升高相关。
- 卒中或TIA后应避免无指征地他汀减量或停药。
核心结论
- 缺血性卒中或TIA后他汀减量或未治疗与较目标剂量组更高的死亡率相关。
研究设计与样本
- 基于2011年美国134家退伍军人健康管理机构电子门诊药房数据的全国性队列研究,共纳入9380例缺血性卒中或TIA患者。
- 依据入院时和出院后7天内他汀效力(低、中、高)将患者分为6组:目标到目标、低到目标、目标到低或目标到无(减量)、无到无、无到低、低到低。
- 采用逻辑回归比较各组30天和1年死亡率,并用倾向加权评分调整基线特征。
主要发现
- 34.1%(n=3194)患者出院时未接受他汀治疗。
- 14.0%(n=1312)患者发生他汀减量,20.5%(n=1924)患者维持无到无。
- 与目标到目标组相比,减量组1年死亡调整OR为1.26(95%CI 1.02–1.57),无到无组为1.59(95%CI 1.30–1.93)。
- 倾向加权评分调整后结果相似。
临床怎么用
- 对缺血性卒中或TIA患者,应评估他汀使用情况,避免无明确指征的减量或停药。
- 出院时应确保多数动脉粥样硬化源性卒中或TIA患者接受中或高效力他汀治疗。
局限性
- 研究人群以白人男性退伍军人为主(白人71.1%,男性96.3%),结果外推需谨慎。
- 为他汀效力分组,未报告具体剂量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Practice guidelines recommend that most patients receive moderate- or high-potency statins after ischemic stroke or transient ischemic attack (TIA) of atherosclerotic origin. We tested the association of different patterns of potency for prescribed statin therapy—assessed before admission and at hospital discharge for ischemic stroke or TIA—on mortality in a large, nationwide sample of US Veterans. METHODS: The study population included patients with an ischemic stroke or TIA occurring during 2011 at any of the 134 Veterans Health Administration facilities. We used electronic outpatient pharmacy files to identify statin dose at hospital admission and within 7 days after hospital discharge. We categorized statin dosing as low, moderate, or high potency; moderate or high potency was considered at goal. We created 6 mutually exclusive groups to reflect patterns of statin potency from hospital admission to discharge: goal to goal, low to goal, goal to low or goal to none (deintensification), none to none, none to low, and low to low. We used logistic regression to compare 30-day and 1-year mortality across statin potency groups. RESULTS: The population included 9380 predominately White (71.1%) men (96.3%) who were hospitalized for stroke or TIA. In this sample, 34.1% of patients (n=3194) were discharged off a statin medication. Deintensification occurred in 14.0% of patients (n=1312) and none to none in 20.5% (n=1924). Deintensification and none to none were associated with a higher odds of mortality as compared with goal to goal (adjusted odds ratio 1-year mortality: deintensification versus goal to goal, 1.26 [95% CI, 1.02–1.57]; none to none versus goal to goal, 1.59 [95% CI, 1.30–1.93]). Adjustments for differences in baseline characteristics using propensity weighted scores demonstrated similar results. CONCLUSIONS: Underutilization of statins, including no treatment or underdosing after stroke (deintensification), was observed in approximately one-third of veterans with ischemic stroke or TIA and was associated with higher mortality when compared with patients who were at goal for statin prescription dosing.
引用
- Dearborn-Tomazos JL, Hu X, Bravata DM, et al. Deintensification or No Statin Treatment Is Associated With Higher Mortality in Patients With Ischemic Stroke or Transient Ischemic Attack. Stroke. 2021. PMID: 34015937. doi:10.1161/STROKEAHA.120.030089
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。